Abstract
Primary disorders of neutrophil function result from impairment in neutrophil responses that are critical for host defense. This chapter summarizes inherited disorders of neutrophils that cause defects in neutrophil adhesion, migration, and oxidative killing. These include the leukocyte adhesion deficiencies, actin defects, and other disorders of chemotaxis, hyperimmunoglobulin E syndrome, Chédiak–Higashi syndrome, neutrophil-specific granule deficiency, chronic granulomatous disease, and myeloperoxidase deficiency. Diagnostic tests and treatment approaches are also summarized for each neutrophil disorder.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Dinauer MC, Coates TD (2012) Disorders of phagocyte function. In: Hoffman (ed) Hematology: basic principles and practice. Elsevier, Philadelphia, Pa, pp 655–673
Lekstrom-Himes JA, Gallin JI (2000) Immunodeficiency diseases caused by defects in phagocytes. N Engl J Med 343:1703–1714
Dale DC et al (2008) The phagocytes: neutrophils and monocytes. Blood 112:935–945
Bouma G et al (2010) Recent advances in the understanding of genetic defects of neutrophil number and function. Br J Haematol 151:312–326
Hanna S, Etzioni A (2012) Leukocyte adhesion deficiencies. Ann N Y Acad Sci 1250:50–55
van de Vijver E et al (2012) Hematologically important mutations: leukocyte adhesion deficiency (first update). Blood Cells Mol Dis 48:53–61
Schymeinsky J et al (2007) Neutrophil activation via beta2 integrins (CD11/CD18): molecular mechanisms and clinical implications. Thromb Haemost 98:262–273
Ambruso DR et al (2000) Human neutrophil immunodeficiency syndrome is associated with an inhibitory Rac2 mutation. Proc Natl Acad Sci USA 97:4654–4659
Williams DA et al (2000) Dominant negative mutation of the hematopoietic-specific Rho GTPase, Rac2, is associated with a human phagocyte immunodeficiency. Blood 96:1646–1654
Roos D et al (1993) A novel syndrome of severe neutrophil dysfunction: unresponsiveness confined to chemotaxin-induced functions. Blood 81:2735–2743
Coates TD et al (1991) An inherited defect of neutrophil motility and microfilamentous cytoskeleton associated with abnormalities in 47-Kd and 89-Kd proteins. Blood 78:1338–1346
Howard T et al (1994) The 47-kD protein increased in neutrophil actin dysfunction with 47- and 89-kD protein abnormalities is lymphocyte-specific protein. Blood 83:231–241
Nunoi H et al (1999) A heterozygous mutation of beta-actin associated with neutrophil dysfunction and recurrent infection. Proc Natl Acad Sci USA 96:8693–8698
Van Dyke TE, Vaikuntam J (1994) Neutrophil function and dysfunction in periodontal disease. Curr Opin Periodontol 28:19–27
Oh TJ et al (2002) Periodontal diseases in the child and adolescent. J Clin Periodontol 29:400–410
Grimbacher B et al (1999) Hyper-IgE syndrome with recurrent infections: an autosomal dominant multisystem disorder. N Engl J Med 340:692–702
Sowerwine KJ et al (2012) Hyper-IgE syndrome update. Ann N Y Acad Sci 1250:25–32
Zhang Q, Su HC (2011) Hyperimmunoglobulin E syndromes in pediatrics. Curr Opin Pediatr 23:653–658
Koenig JM, Yoder MC (2004) Neonatal neutrophils: the good, the bad, and the ugly. Clin Perinatol 31:39–51
Hill HR (1987) Biochemical, structural, and functional abnormalities of polymorphonuclear leukocytes in the neonate. Pediatr Res 22:375–382
Kaplan J et al (2008) Chediak-Higashi syndrome. Curr Opin Hematol 15:22–29
Introne WJ et al (2010) Chediak-Higashi syndrome. In: Pagon RA, Bird TD, Dolan CR, Stephens K, Adam MP (eds) GeneReviews. University of Washington, Seattle, WA
Janka GE (2012) Familial and acquired hemophagocytic lymphohistiocytosis. Annu Rev Med 63:233–246
Gallin JI (1985) Neutrophil specific granule deficiency. Annu Rev Med 36:263–274
Gombart AF, Koeffler HP (2002) Neutrophil specific granule deficiency and mutations in the gene encoding transcription factor C/EBP(epsilon). Curr Opin Hematol 9:36–42
Lekstrom-Himes JA et al (1999) Neutrophil-specific granule deficiency results from a novel mutation with loss of function of the transcription factor CCAAT/enhancer binding protein epsilon. J Exp Med 189:1847–1852
Dinauer MC (2005) Chronic granulomatous disease and other disorders of phagocyte function. Hematology Am Soc Hematol Educ Program 2005:89–95
Seger RA (2008) Modern management of chronic granulomatous disease. Br J Haematol 140:255–266
Schappi MG et al (2008) Hyperinflammation in chronic granulomatous disease and anti-inflammatory role of the phagocyte NADPH oxidase. Semin Immunopathol 30:255–271
Matute JD et al (2009) A new genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40 phox and selective defects in neutrophil NADPH oxidase activity. Blood 114:3309–3315
Kang EM et al (2011) Chronic granulomatous disease: overview and hematopoietic stem cell transplantation. J Allergy Clin Immunol 127:1319–1326
Kuhns DB et al (2010) Residual NADPH oxidase and survival in chronic granulomatous disease. N Engl J Med 363:2600–2610
Roos D et al (2010) Hematologically important mutations: the autosomal recessive forms of chronic granulomatous disease (second update). Blood Cells Mol Dis 44:291–299
Roos D et al (2010) Hematologically important mutations: X-linked chronic granulomatous disease (third update). Blood Cells Mol Dis 45:246–265
Bustamante J et al (2011) Germline CYBB mutations that selectively affect macrophages in kindreds with X-linked predisposition to tuberculous mycobacterial disease. Nat Immunol 12:213–221
Al Ghouleh I et al (2011) Oxidases and peroxidases in cardiovascular and lung disease: new concepts in reactive oxygen species signaling. Free Radic Biol Med 51:1271–1288
Roesler J et al (2000) Recombination events between the p47-phox gene and its highly homologous pseudogenes are the main cause of autosomal recessive chronic granulomatous disease. Blood 95:2150–2156
Vowells SJ et al (1996) Genotype-dependent variability in flow cytometric evaluation of reduced nicotinamide adenine dinucleotide phosphate oxidase function in patients with chronic granulomatous disease. J Pediatr 128:104–107
Foster CB et al (1998) Host defense molecule polymorphisms influence the risk for immune-mediated complications in chronic granulomatous disease. J Clin Invest 102:2146–2155
Vowells SJ et al (1995) Flow cytometric analysis of the granulocyte respiratory burst: a comparison study of fluorescent probes. J Immunol Methods 178:89–97
Gallin JI et al (2003) Itraconazole to prevent fungal infections in chronic granulomatous disease. N Engl J Med 348:2416–2422
Marciano BE et al (2004) Long-term interferon-gamma therapy for patients with chronic granulomatous disease. Clin Infect Dis 39:692–699
The International Chronic Granulomatous Disease Cooperative Study Group (1991) A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. N Engl J Med 324:509–516
Grez M et al (2011) Gene therapy of chronic granulomatous disease: the engraftment dilemma. Mol Ther 19:28–35
Klebanoff SJ et al (2013) Myeloperoxidase: a front-line defender against phagocytosed microorganisms. J Leukoc Biol 93:185–198
Beutler E (1994) G6PD deficiency. Blood 84:3613–3636
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Dinauer, M.C. (2014). Disorders of Neutrophil Function: An Overview . In: Quinn, M., DeLeo, F. (eds) Neutrophil Methods and Protocols. Methods in Molecular Biology, vol 1124. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-845-4_30
Download citation
DOI: https://doi.org/10.1007/978-1-62703-845-4_30
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-844-7
Online ISBN: 978-1-62703-845-4
eBook Packages: Springer Protocols